Christopher A. Viehbacher
Chief executive: Biogen Inc. (14 Nov 2022 to present)
2commitments announced
2with a clear outcome
2met on time
–rate shown after 15 outcomes
Commitments are credited to the chief executive in office on the day they were announced. Where a deadline fell after the leader left, the entry is marked. Sources for each leadership change: Biogen Inc. filing.
Commitments announced under Christopher A. Viehbacher
| Biogenannounced 8 Nov 2023 | Make ZURZUVAE commercially available in the U.S | Met31 Dec 2023 |
| Biogenannounced 28 Jul 2023 | Close the acquisition of Reata Pharmaceuticals | Met31 Dec 2023 |
Is this record wrong, or are you Christopher A. Viehbacher? Add a statement or ask for a correction.